Evolution of the Average Target: Amarin Corporation plc

Evolution of the Average Target - Amarin Corporation plc

Evolution of the Target Price: Amarin Corporation plc

Evolution of the Target Price - Amarin Corporation plc

Changes in Analyst Recommendations: Amarin Corporation plc

92bb4f31.Jxvady9uMGsmdLTSJLJub0BxmF1Hq4UGpfqkSOODnUw.FCvrH0wqXidLJMG3E8oDNXg57msB_-4yzrTiIKTQxBhLT4MiaAlSAXEthA~8c0357c2f7b7791dcc6790e483a09640
28/10/25 Amarin issues statement supporting FDA's action to revise labeling for fenofibrate drugs reinforcing a lack of cardiovascular benefit RE
25/06/25 RBC Ups Recordati's Price Target on Cardiovascular Drug European Licensing Deal MT
25/10/23 Jefferies Downgrades Amarin to Hold From Buy, Cuts Price Target to $1 From $3 MT
20/07/23 Northland Adjusts Price Target on Amarin to $1.25 From $2, Maintains Market Perform Rating MT
07/01/23 Jefferies Upgrades Amarin to Buy From Hold, Adjusts Price Target to $3 From $1.30 MT
20/10/22 SVB Securities Adjusts Amarin's Price Target to $2 From $3, Maintains Market Perform Rating MT
06/05/22 JPMorgan Downgrades Amarin to Underweight From Neutral MT
05/05/22 HC Wainwright Lowers Amarin to Neutral From Buy, Price Target to $3 From $10 MT
05/05/22 SVB Leerink Downgrades Amarin to Market Perform From Outperform, Adjusts Price Target to $3 From $10 MT
05/05/22 Northland Downgrades Amarin to Market Perform From Outperform, Adjusts Price Target to $2 From $9 MT
17/02/22 SVB Leerink Adjusts Amarin's Price Target to $10 from $11, Maintains Outperform Rating MT
01/02/22 SVB Leerink Adjusts Amarin's Price Target to $11 from $12, Keeps Outperform Rating MT
12/05/21 Amarin : Goldman Sachs Downgrades Amarin to Sell From Neutral, Adjusts Price Target to $5 From $6 MT
02/02/21 Amarin : SVB Leerink Adjusts Price Target on Amarin to $16 From $12, Maintains Outperform Rating MT
24/12/20 Amarin : Goldman Sachs Adjusts Amarin's Price Target to $6 From $8, Maintains Neutral Rating MT
08/12/20 Amarin : Citigroup Adjusts Amarin's Price Target to $7 from $12, Maintains Buy Rating MT

Consensus Analysts' recommendations evolution (4 months) Financial estimates divergence Analysts' Target price divergence Objective/dr gap
- -1.85%
+41.6%
+24.9%
+8.71%
+12.62%
+17.47%
+36.04%
+1%
+42.98%
+33.85%
Average +21.73%
Weighted average by Cap. +24.29%


Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
SELL
Number of Analysts
2
Last Close Price
12.11USD
Average target price
12.50USD
Spread / Average Target
+3.22%
High Price Target
13.00USD
Spread / Highest target
+7.35%
Low Price Target
12.00USD
Spread / Lowest Target
-0.91%

Analyst Consensus Detail

Analyst consensus - Amarin Corporation plc

Consensus revision (last 18 months)

Consensus revision (last 18 months) - Amarin Corporation plc
Trader
Investor
-
Global
-
Quality
-
ESG MSCI
-
MarketScreener Ratings - Amarin Corporation plc
  1. Stock Market
  2. Stocks
  3. AMRN Stock
  4. Consensus Amarin Corporation plc